| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.70.4.724 |
| P953 | full work available at URL | https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.70.4.724 |
| P698 | PubMed publication ID | 6332687 |
| P5875 | ResearchGate publication ID | 16862976 |
| P50 | author | Keith Fox | Q72227369 |
| P2093 | author name string | B. E. Sobel | |
| M. J. Welch | |||
| S. R. Bergmann | |||
| A. L. Rand | |||
| J. Markham | |||
| K. D. McElvany | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cardiology and cardiovascular medicine | Q96320350 |
| P304 | page(s) | 724-733 | |
| P577 | publication date | 1984-10-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Quantification of regional myocardial blood flow in vivo with H215O | |
| P478 | volume | 70 |
| Q42392943 | (82)Rb PET imaging of myocardial blood flow-have we achieved the 4 "R"s to support routine use? |
| Q57620882 | 15-O-water myocardial flow reserve PET and CT angiography by full hybrid PET/CT as a potential alternative to invasive angiography |
| Q42275636 | A convenient route to [68Ga]Ga-MAA for use as a particulate PET perfusion tracer |
| Q30489810 | A look-locker acquisition scheme for quantitative myocardial perfusion imaging with FAIR arterial spin labeling in humans at 3 tesla |
| Q70274087 | A new subtraction method for obtaining myocardial perfusion images with oxygen-15 water and positron emission tomography |
| Q57621344 | ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures |
| Q47810721 | Accurate myocardial T1 measurements: toward quantification of myocardial blood flow with arterial spin labeling. |
| Q34122275 | An overview of radiotracers in nuclear cardiology. |
| Q37762484 | Anatomy and physiology of coronary blood flow |
| Q79501862 | Assessment of coronary flow reserve by sestamibi imaging in patients with typical chest pain and normal coronary arteries |
| Q37177659 | Assessment of coronary flow reserve using single photon emission computed tomography with technetium 99m-labeled tracers. |
| Q40635568 | Assessment of endothelial function and myocardial flow reserve using (15)O-water PET without attenuation correction |
| Q38673413 | Assessment of myocardial blood flow and coronary flow reserve with positron emission tomography in ischemic heart disease: current state and future directions |
| Q61455191 | Assessment of myocardial perfusion by dynamic O-15–labeled water PET imaging: Validation of a new fast factor analysis |
| Q37721712 | Assessment of myocardial perfusion by positron emission tomography |
| Q45969460 | Assessment of the arterial input function for estimation of coronary flow reserve by single photon emission computed tomography: comparison of two different approaches. |
| Q34757040 | Automatic generation of absolute myocardial blood flow images using [15O]H2O and a clinical PET/CT scanner |
| Q37586992 | Blood perfusion in osteomyelitis studied with [15O]water PET in a juvenile porcine model. |
| Q50261674 | Burton Elias Sobel, MD: a conversation with the editor. Interview by William Clifford Roberts |
| Q47228892 | Calculation of left ventricular volumes and ejection fraction from dynamic cardiac-gated 15O-water PET/CT: 5D-PET. |
| Q35097258 | Cardiac PET perfusion tracers: current status and future directions |
| Q39686243 | Cardiac PET, CT, and MR: what are the advantages of hybrid imaging? |
| Q37957539 | Cardiac hybrid imaging |
| Q77504781 | Cardiac positron emission tomography |
| Q69878089 | Cardiac positron emission tomography |
| Q90678655 | Cardiovascular Imaging Techniques to Assess Microvascular Dysfunction |
| Q73246323 | Clinical methods to determine coronary flow and myocardial perfusion |
| Q38723494 | Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM). |
| Q40566745 | Comparison of modalities to diagnose coronary artery disease |
| Q37639667 | Computed tomography myocardial perfusion vs 15O-water positron emission tomography and fractional flow reserve |
| Q48423415 | Construction of a whole body blood flow model for use in positron emission tomography imaging with [15O]water |
| Q42551881 | Coronary flow reserve is impaired in young men with familial hypercholesterolemia |
| Q38259726 | Coronary microvascular dysfunction: mechanisms and functional assessment |
| Q37638427 | Coronary vasomotor function assessed by positron emission tomography |
| Q39656963 | Current status and prospects of new radionuclides and radiopharmaceuticals for cardiovascular nuclear medicine |
| Q35826639 | Cyclotrons and positron emission tomography radiopharmaceuticals for clinical imaging |
| Q72549957 | Difference in regional hepatic blood flow in liver segments--non-invasive measurement of regional hepatic arterial and portal blood flow in human by positron emission tomography with H2(15)O |
| Q53544305 | Direct comparison between 2-dimensional and 3-dimensional PET acquisition modes for myocardial blood flow absolute quantification with O-15 water and N-13 ammonia. |
| Q59845610 | EEC concerted action on cellular degeneration and regeneration studied with PET |
| Q40095975 | Early intervention in acute myocardial infarction: One center's perspective |
| Q68805807 | Enhancement of salvage of reperfused ischemic myocardium by diltiazem |
| Q51982586 | Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: comparison with the results of intracoronary Doppler technique. |
| Q80041531 | Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries |
| Q53574949 | Evaluation of basis function and linear least squares methods for generating parametric blood flow images using 15O-water and Positron Emission Tomography. |
| Q71516081 | Experimental verification of technetium 99m-labeled teboroxime kinetic parameters in the myocardium with dynamic single-photon emission computed tomography: reproducibility, correlation to flow, and susceptibility to extravascular contamination |
| Q36331843 | F-18 fluorodeoxyglucose uptake and water-perfusable tissue fraction in assessment of myocardial viability. |
| Q68807462 | Features of positron emission tomography as a probe for myocardial chemistry |
| Q52677879 | First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study. |
| Q45952718 | Hybrid CT angiography and quantitative 15O-water PET for assessment of coronary artery disease: comparison with quantitative coronary angiography. |
| Q57622511 | Hybrid SPECT-CT and PET-CT: Current Concepts and Developments |
| Q30982569 | In vivo functional NMR imaging of resistance artery control |
| Q49147438 | Ischemic heart disease: assessment with gadolinium-enhanced ultrafast MR imaging and dipyridamole stress |
| Q50012538 | Lost in quantification…: The influence of different software packages on flow quantification measures |
| Q59845550 | Measurement of liver blood flow using oxygen-15 labelled water and dynamic positron emission tomography: Limitations of model description |
| Q33720443 | Methods for evaluating coronary microvasculature in humans. |
| Q34440461 | Modeling regional myocardial flows from residue functions of an intravascular indicator |
| Q30407070 | Multimodality and nanoparticles in medical imaging |
| Q36640008 | Muscle blood flow and oxygenation measured by NMR imaging and spectroscopy. |
| Q42092326 | Myocardial hibernation and stunning: from physiological principles to clinical practice. |
| Q59515630 | Myocardial perfusion imaging with PET |
| Q33613415 | Myocardial perfusion in humans: what can we measure? |
| Q35067483 | Non-local means denoising of dynamic PET images |
| Q37826116 | Novel F-18-labeled PET myocardial perfusion tracers: bench to bedside |
| Q60607007 | Nuclear cardiology needs new “blood” |
| Q43231231 | Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes. |
| Q37896144 | PET and PET/CT in cardiovascular disease |
| Q38075810 | PET and SPECT in heart failure |
| Q33802855 | PET measurement of the coronary flow reserve and microcirculatory function |
| Q40846516 | PET radiopharmaceuticals: state-of-the-art and future prospects |
| Q38167018 | PET tracers and techniques for measuring myocardial blood flow in patients with coronary artery disease |
| Q38021718 | PET: Is myocardial flow quantification a clinical reality? |
| Q51955951 | Parametric image of myocardial blood flow generated from dynamic H2(15)O PET using factor analysis and cluster analysis. |
| Q35217711 | Pathophysiology and diagnosis of hibernating myocardium in patients with post-ischemic heart failure: the contribution of PET. |
| Q57824847 | Positron Emission Tomography in the Diagnosis and Management of Coronary Artery Disease |
| Q35905002 | Positron emission tomographic imaging of angiogenesis and vascular function. |
| Q37973120 | Positron emission tomography as an aid in understanding electrocardiographic changes of ischemia, infarction, and cardiomyopathy |
| Q35856361 | Positron emission tomography for quantitation of myocardial perfusion |
| Q45007821 | Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease |
| Q37200626 | Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC). |
| Q44143803 | Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coron |
| Q72664957 | Quantification and parametric imaging of renal cortical blood flow in vivo based on Patlak graphical analysis |
| Q37769444 | Quantification of myocardial blood flow and flow reserve: Technical aspects |
| Q37270541 | Quantification of myocardial blood flow with (82)Rb: Validation with (15)O-water using time-of-flight and point-spread-function modeling |
| Q35928796 | Quantification of myocardial blood flow with 82Rb positron emission tomography: clinical validation with 15O-water. |
| Q52936656 | Quantitative Assessment of Coronary Microvascular Function: Dynamic Single-Photon Emission Computed Tomography, Positron Emission Tomography, Ultrasound, Computed Tomography, and Magnetic Resonance Imaging. |
| Q53285400 | Quantitative analysis of coronary endothelial function with generator-produced 82Rb PET: comparison with 15O-labelled water PET. |
| Q37288099 | Quantitative cardiac positron emission tomography: the time is coming! |
| Q52290662 | Quantitative evaluation of manganese-52m as a myocardial perfusion tracer in pigs using positron emission tomography. |
| Q35547364 | Quantitative imaging of coronary blood flow |
| Q37562248 | Quantitative myocardial blood flow imaging with integrated time-of-flight PET-MR. |
| Q51608129 | Regional myocardial perfusion and metabolism assessed by positron emission tomography in children with Kawasaki disease and significance of abnormal Q waves and their disappearance |
| Q37124138 | Resting myocardial perfusion quantification with CMR arterial spin labeling at 1.5 T and 3.0 T. |
| Q36017117 | Role of PET in the evaluation and understanding of coronary physiology. |
| Q90455305 | Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation |
| Q52390881 | Techniques for the measurement of the local myocardial extraction efficiency for inert diffusible contrast agents such as gadopentate dimeglumine. |
| Q35932356 | The contribution of hibernation to heart failure |
| Q35605420 | The perfusable tissue index: a marker of myocardial viability |
| Q37875793 | The role of cardiac PET in translating basic science into the clinical arena |
| Q59845601 | The significance of a dipyridamole induced 99mTc-MIBI perfusion abnormality on single photon emission tomography: a quantitative validation with labelled water and positron emission tomography |
| Q34122272 | Tracer kinetic modeling in nuclear cardiology |
| Q57988200 | Validation of pixel-wise parametric mapping of myocardial blood flow with 13NH3 PET in patients with hypertrophic cardiomyopathy |
| Q36843306 | Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow? |
| Q73391294 | [Examination of myocardial perfusion with positron emission tomography: a clinically useful and valid method?] |
| Q74353826 | [Functional radionuclide imaging in cardiac failure] |
| Q73661449 | [Nuclear cardiology: technical bases and clinical applications] |
| Q73303497 | [The clinical management guidelines of the Sociedad Española de Cardiología. Nuclear cardiology: the technical bases and clinical applications] |
Search more.